Cardiac Amyloidosis

• CLINICAL_TRIALS trial_result · 2017-10-17
  Clinical Trial Update: A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL) [Phase 2]

  This update notes the completion of a Phase 2 trial evaluating epigallocatechin-3-gallate (EGCG) for cardiac involvement in light chain (AL)…

• CLINICAL_TRIALS trial_result · 2016-07-20
  Clinical Trial Update: DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis

  A completed observational trial (DISCOVERY) evaluated the prevalence of transthyretin (TTR) mutations in subjects suspected of having cardia…